Melanoma Posts on Medivizor
Navigation Menu

Melanoma Posts on Medivizor

What are the benefits of combined dabrafenib and trametinib on patient-reported outcomes?

Posted by on Apr 28, 2019 in Melanoma | 0 comments

In a nutshell This study investigated the effect of dabrafenib (Tafinlar and trametinib (Mekinist) on patient-reported outcomes (PROs) in melanoma. They found that this treatment combination did not effect PROs. Some background Melanoma is a type of skin cancer. The prognosis for melanoma has improved in recent years. Targeted therapies...

Read More

Influenza vaccination and immune-checkpoint inhibitors – what are the risks to patients with cancer?

Posted by on Mar 31, 2019 in Melanoma | 0 comments

In a nutshell This study investigated the effect of immune-checkpoint inhibitors (ICIs) on influenza vaccination in patients with cancer. They found that influenza vaccination is safe in these patients Some background Immune-checkpoint inhibitors (ICIs) are a new type of drug to treat cancer. ICIs can be effective in some advanced cancers,...

Read More

Side effects with vemurafenib/cobimetinib in advanced melanoma: is there an impact on survival?

Posted by on Mar 31, 2019 in Melanoma | 0 comments

In a nutshell This study investigated the impact of adverse events (AEs) of treatment with vemurafenib (Zelboraf) and cobimetinib (Cotellic) on survival in patients with melanoma. They found that early side effects requiring dose reduction had a positive effect on treatment outcomes.   Some background Some melanoma tumors are caused by...

Read More

Is ultrasound surveillance of lymph nodes safe in patients with medium-risk melanoma?

Posted by on Mar 22, 2019 in Melanoma | 0 comments

In a nutshell This study wanted to find out if performing ultrasounds and performing clinical exams is a safe option to catch cancer that has spread to the lymph nodes in patients with melanoma. The study found that a significant number of tumors were found in lymph nodes by performing this type of surveillance. Some background The most common...

Read More

TVEC therapy for patients with advanced stage melanoma

Posted by on Mar 5, 2019 in Melanoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of talimogene laherparepvec (TVEC) therapy for patients with melanoma that cannot be surgically removed (unresectable). The study found that TVEC therapy is an effective treatment for these patients, with minimal side effects. Some background Patients with localized melanoma that is...

Read More

TVEC therapy for patients with advanced stage melanoma

Posted by on Mar 5, 2019 in Melanoma | 0 comments

In a nutshell This study evaluated the safety and effectiveness of talimogene laherparepvec (TVEC) therapy for patients with melanoma that cannot be surgically removed (unresectable). The study found that TVEC therapy is an effective treatment for these patients, with minimal side effects. Some background Patients with localized melanoma that is...

Read More

Survival in patients with melanoma treated with pembrolizumab

Posted by on Feb 20, 2019 in Melanoma | 0 comments

In a nutshell This study wanted to find out what the survival rates are of patients with melanoma treated with pembrolizumab (Keytruda). The study found that after 5 years, there was a good response to treatment overall. Some background Pembrolizumab is a new cancer treatment. It treats many different types of cancer. It works by using the immune...

Read More